Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Hess

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
NPJ Digital Medicine|August 19, 2023
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patientsSebastian Klein, Nora Wuerdemann, Imke Demers, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancerManu Prasad, Jonathan Zorea, Sankar Jagadeeshan, et al.
International Journal of Cancer|October 14, 2021
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapyBouchra Tawk, Ute Wirkner, Christian Schwager, et al.
International Journal of Cancer|May 29, 2019
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancerKatrin Schmitt, Britta Molfenter, Natalia Koerich Laureano, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
NPJ Digital Medicine|August 19, 2023
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patientsSebastian Klein, Nora Wuerdemann, Imke Demers, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancerManu Prasad, Jonathan Zorea, Sankar Jagadeeshan, et al.
International Journal of Cancer|October 14, 2021
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapyBouchra Tawk, Ute Wirkner, Christian Schwager, et al.
International Journal of Cancer|May 29, 2019
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancerKatrin Schmitt, Britta Molfenter, Natalia Koerich Laureano, et al.
Pageof 15